Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study

dc.authoridSaadettin Kılıçkap / 0000-0003-1637-7390
dc.authorscopusidSaadettin Kılıçkap / 8665552100
dc.authorwosidSaadettin Kılıçkap / DXP-4273-2022
dc.contributor.authorYekedüz, Emre
dc.contributor.authorÖzbay, Mehmet Fatih
dc.contributor.authorÇağlayan, Dilek
dc.contributor.authorYıldırım, Atila
dc.contributor.authorErol, Cihan
dc.contributor.authorYıldırım, Hasan Çağrı
dc.contributor.authorTunç, Sezai
dc.contributor.authorÖzyurt, Neslihan
dc.contributor.authorÖzdemir, Feyyaz
dc.contributor.authorŞendur, Mehmet Ali Nahit
dc.contributor.authorKılıçkap, Saadettin
dc.date.accessioned2022-04-25T08:30:18Z
dc.date.available2022-04-25T08:30:18Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractClinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter studyen_US
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.130en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issue4en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2022.40.4_suppl.130
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2655
dc.identifier.volume40en_US
dc.identifier.wosWOS:000770995900126en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorKılıçkap, Saadettin
dc.language.isoenen_US
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleClinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter studyen_US
dc.typeOtheren_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: